Related Experiment Video
Updated: Jun 21, 2026
07:56
A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
On the mechanism of the acute decrease of rat brain tryptophan hydroxylase activity by 4-chloroamphetamine
1Research and Development Laboratories, Astra Läkemedel AB, S-151 85 Södertälje Sweden.
Neuroscience Letters
|July 17, 2009
Summary
4-chloroamphetamine reduces rat brain tryptophan hydroxylase activity. This effect is linked to serotonin release and receptor stimulation, as shown by antagonization with zimelidine and other agents.
Area of Science:
- Neuropharmacology
- Biochemistry
Background:
- Tryptophan hydroxylase is the rate-limiting enzyme in serotonin synthesis.
- 4-chloroamphetamine (4-CA) is known to affect serotonin levels and related enzyme activities.
Purpose of the Study:
- To investigate the mechanism behind the decrease in rat brain soluble tryptophan hydroxylase activity following 4-chloroamphetamine administration.
- To explore the role of serotonin (5-HT) release and receptor activity in this process.
Main Methods:
- Rats were injected with 4-chloroamphetamine (20 mg/kg i.p.).
- The effects of zimelidine (serotonin uptake inhibitor), chlorpromazine, and methergoline (5-HT receptor antagonist) on tryptophan hydroxylase activity were assessed.
- Reserpine was used to investigate the role of serotonin depletion.
Main Results:
- 4-chloroamphetamine significantly decreased soluble tryptophan hydroxylase activity.
- Zimelidine, chlorpromazine, and methergoline antagonized this decrease when pre-administered.
- Zimelidine partially reversed the effect when administered post-4-CA.
- Reserpine prevented the decrease when given 18 hours prior, but not 1 hour prior.
Conclusions:
- The reduction in tryptophan hydroxylase activity by 4-chloroamphetamine is likely secondary to serotonin release.
- This effect appears to be mediated by the stimulation of central serotonin receptors.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...